U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9579195791Salivary Phosphorus and Level of Kidney FunctionCompletedNo Results AvailableChronic Kidney Diseasehttps://ClinicalTrials.gov/show/NCT01311973
9579295792Topical Bevacizumab for Preventing Recurrent PterygiumCompletedNo Results AvailablePterygium|Bevacizumab|VEGF|Anti-VEGFDrug: bevacizumab eye drop 0.05%|Drug: normal saline 0.9%https://ClinicalTrials.gov/show/NCT01311960
9579395793Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis BCompletedNo Results AvailableHepatitis B, ChronicDrug: Peginterferon alfa-2ahttps://ClinicalTrials.gov/show/NCT01311947
9579495794Visceral Stiffness Measurement Using Acoustic Radiation Force ImpulseRecruitingNo Results AvailableVisceral Stiffness|Liver Fibrosishttps://ClinicalTrials.gov/show/NCT01311934
9579595795Children's Susceptibility to Enterovirus 71 in Different Areas of TaiwanEnrolling by invitationNo Results AvailableEnterovirus 71, Host Genetics, Social, Behavior, Environmental Factorshttps://ClinicalTrials.gov/show/NCT01311921
9579695796Incidence of Reflux Esophagitis After PancreaticoduodenectomyRecruitingNo Results AvailableReflux EsophagitisProcedure: Methods of gastrojejunostomy reconstructionhttps://ClinicalTrials.gov/show/NCT01311908
9579795797Clinical Trial Comparing Two Protocols Using Intravenous (IV) HydromorphoneRecruitingNo Results AvailableAcute PainDrug: H2O|Drug: 1+1https://ClinicalTrials.gov/show/NCT01311895
9579895798A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)CompletedNo Results AvailableInsomniaDrug: MK-4305 40 mg|Drug: MK-4305 20 mg|Drug: Zopiclone|Drug: Grossly Matching Placebo for Zopiclone|Drug: Matching Placebo for MK-4305https://ClinicalTrials.gov/show/NCT01311882
9579995799Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine FibroidsTerminatedNo Results AvailableLeiomyomaDietary Supplement: EGCG ( Green Tea extract)|Dietary Supplement: Brown rice pillshttps://ClinicalTrials.gov/show/NCT01311869
9580095800Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer SurvivorsActive, not recruitingNo Results AvailableBreast Cancer|Colorectal Cancer|Prostate CancerBehavioral: Standard Arm (mail/telephone)|Behavioral: Internet Arm|Behavioral: Surveys and Questionnaires|Behavioral: Exercise and Diethttps://ClinicalTrials.gov/show/NCT01311856
9580195801Enhancing Smoker Utilization of the Minnesota Quitline Through Support PersonsCompletedNo Results AvailableTobacco UseBehavioral: Telephone Counseling|Behavioral: Written Materialshttps://ClinicalTrials.gov/show/NCT01311830
9580295802Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector VaccineCompletedNo Results AvailableImmunological Stimulation|Attenuated VaccineBiological: BMB72 (actA/plcB-deleted Listeria monocytogenes expressing influenza A nucleoprotein)https://ClinicalTrials.gov/show/NCT01311817
9580395803An Efficacy and Safety Study of Periarticular Parecoxib Sodium for Pain Management in Total Knee ArthroplastyNot yet recruitingNo Results AvailableUnilateral Primary Osteoarthritis of KneeProcedure: parecoxib sodium|Procedure: parecoxib sodiumhttps://ClinicalTrials.gov/show/NCT01311804
9580495804A Randomized, Controlled Study to Evaluate Algisyl-LVRâ„¢ as a Method of Left Ventricular Augmentation for Heart FailureActive, not recruitingNo Results AvailableHeart Failure|Dilated CardiomyopathyDevice: Algisyl-LVR|Drug: Standard medical therapyhttps://ClinicalTrials.gov/show/NCT01311791
9580595805Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid RelapseCompletedNo Results AvailableOpiate AddictionDrug: Cannabidiol|Drug: Fentanylhttps://ClinicalTrials.gov/show/NCT01311778
9580695806Duration of Antibiotic Therapy in the Treatment of Severe Postoperative Peritonitis Admitted in ICUActive, not recruitingNo Results AvailablePostoperative PeritonitisOther: Duration of antibiotic therapy limited to 8 dayshttps://ClinicalTrials.gov/show/NCT01311765
9580795807Study of Human Papillomavirus Related Genital Pathology Among HIV Positive WomenCompletedNo Results AvailableHIV InfectionsProcedure: surgical management of high grade lesionshttps://ClinicalTrials.gov/show/NCT01311752
9580895808Oral Cyanocobalamin (Eligen B12) Bioavailability StudyCompletedNo Results AvailableHealthyDrug: Cyanocobalaminhttps://ClinicalTrials.gov/show/NCT01311739
9580995809[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01311726
9581095810Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid TumorsTerminatedNo Results AvailableSolid TumorsDrug: CEP-9722|Drug: CEP-9722https://ClinicalTrials.gov/show/NCT01311713
9581195811Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial.Active, not recruitingNo Results AvailableMyocardial Infarction.Drug: Injectable (i.v.) metoprolol tartrate (up to 15 mg).https://ClinicalTrials.gov/show/NCT01311700
9581295812A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory MultiActive, not recruitingHas ResultsMultiple MyelomaDrug: pomalidomide|Drug: dexamethasonehttps://ClinicalTrials.gov/show/NCT01311687
9581395813Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)Active, not recruitingNo Results AvailableHealthy VolunteersBiological: hepatitis B vaccine|Biological: hepatitis B vaccinehttps://ClinicalTrials.gov/show/NCT01311674
9581495814A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe AsthmaCompletedHas ResultsAsthmaDrug: Placebo twice daily|Drug: Olodaterol low daily dose twice daily|Drug: Olodaterol medium daily dose twice daily|Drug: Placebo twice daily|Drug: Olodaterol high daily dose once daily and placebo|Drug: Olodaterol medium daily dose once daily and placebohttps://ClinicalTrials.gov/show/NCT01311661
9581595815BAY81-8973 Pediatric Safety and Efficacy TrialRecruitingNo Results AvailableHaemophilia ABiological: Recombinant Factor VIII (BAY81-8973)https://ClinicalTrials.gov/show/NCT01311648
9581695816A Bioavailability Study Comparing 3 Different AZD1981 TabletsCompletedNo Results AvailableHealthyDrug: AZD1981, current small-particle tablet|Drug: AZD1981, new small-particle tablet|Drug: AZD1981, new large-particle tablehttps://ClinicalTrials.gov/show/NCT01311635
9581795817Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy SubjectsCompletedNo Results AvailableRheumatoid Arthritis|Healthy SubjectsDrug: warfarin|Drug: fostamatinibhttps://ClinicalTrials.gov/show/NCT01311622
9581895818A Multi-Site Post Marketing Surveillance Study for Systane in Indian PatientsCompletedNo Results AvailableModerate to Severe Dry EyeOther: Systanehttps://ClinicalTrials.gov/show/NCT01311609
9581995819Show Me to Help MeCompletedNo Results AvailableAutismOther: Iconshttps://ClinicalTrials.gov/show/NCT01311596
9582095820Evaluating Teach Back as a Method for Improving Self-Care Behaviours in Heart Failure PatientsActive, not recruitingNo Results AvailableHeart FailureBehavioral: Teach Back method of patient discharge teachinghttps://ClinicalTrials.gov/show/NCT01311583

* Görseller ve İçerik tekif hakkına sahip olabilir